Black Diamond Financial LLC Has $643,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Black Diamond Financial LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,272 shares of the healthcare conglomerate’s stock after buying an additional 51 shares during the quarter. Black Diamond Financial LLC’s holdings in UnitedHealth Group were worth $643,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp raised its position in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the period. Geode Capital Management LLC raised its position in shares of UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. raised its position in shares of UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the period. Fisher Asset Management LLC raised its position in UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after buying an additional 107,097 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in UnitedHealth Group by 0.5% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,619,549 shares of the healthcare conglomerate’s stock valued at $1,325,125,000 after buying an additional 12,322 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on UNH shares. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $465.58 on Monday. The stock has a market cap of $428.46 billion, a P/E ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. The stock has a 50 day simple moving average of $519.27 and a 200 day simple moving average of $560.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.